We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
-4.52%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$99.7M
AUM Growth
-$7.72M
Cap. Flow
-$1.97M
Cap. Flow %
-1.98%
Top 10 Hldgs %
20.61%
Holding
65
New
2
Increased
1
Reduced
60
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.85M
2
KR icon
Kroger
KR
+$1.74M
3
MDT icon
Medtronic
MDT
+$31.9K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$1.33M
2
GPC icon
Genuine Parts
GPC
+$288K
3
WBD icon
Warner Bros
WBD
+$149K
4
AMGN icon
Amgen
AMGN
+$149K
5
NXST icon
Nexstar Media Group
NXST
+$86.9K

Sector Composition

Rank Sector Weight
1 Financials 20.76%
2 Healthcare 18.69%
3 Industrials 10.11%
4 Technology 10.09%
5 Energy 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
26
Qualcomm
QCOM
$170B
$1.72M 1.73%
15,249
-547
-3% -$75.2K
LOW icon
27
Lowe's Companies
LOW
$125B
$1.71M 1.71%
9,089
-327
-3% -$63.7K
LMT icon
28
Lockheed Martin
LMT
$137B
$1.67M 1.68%
4,333
-155
-3% -$64.7K
PRU icon
29
Prudential Financial
PRU
$42.2B
$1.64M 1.65%
19,164
-667
-3% -$64.2K
AES icon
30
AES
AES
$10.5B
$1.64M 1.64%
72,491
-2,608
-3% -$61.8K
AVGO icon
31
Broadcom
AVGO
$1.99T
$1.63M 1.64%
36,810
-1,320
-3% -$67.4K
KR icon
32
Kroger
KR
$34.3B
$1.6M 1.61%
+36,626
New +$1.74M
PFE icon
33
Pfizer
PFE
$151B
$1.59M 1.6%
36,372
-1,445
-4% -$70.2K
BMY icon
34
Bristol-Myers Squibb
BMY
$130B
$1.59M 1.59%
22,309
-881
-4% -$63.9K
MSFT icon
35
Microsoft
MSFT
$3.73T
$1.59M 1.59%
6,810
-243
-3% -$64.2K
UPS icon
36
United Parcel Service
UPS
$88.4B
$1.58M 1.58%
9,783
-355
-4% -$67.2K
PKG icon
37
Packaging Corp of America
PKG
$22.9B
$1.56M 1.57%
13,940
-496
-3% -$67.1K
ENB icon
38
Enbridge
ENB
$113B
$1.56M 1.56%
41,972
-1,543
-4% -$65.1K
CMI icon
39
Cummins
CMI
$87.5B
$1.53M 1.53%
7,520
-267
-3% -$56.8K
IPG
40
DELISTED
Interpublic Group of Companies
IPG
$1.49M 1.5%
58,354
-2,058
-3% -$58.4K
TRP icon
41
TC Energy
TRP
$66.6B
$1.47M 1.48%
36,468
-1,208
-3% -$59.9K
ORI icon
42
Old Republic International
ORI
$10.3B
$1.46M 1.47%
69,812
-2,508
-3% -$56.5K
CSCO icon
43
Cisco
CSCO
$476B
$1.46M 1.46%
36,462
-1,301
-3% -$57.7K
JNJ icon
44
Johnson & Johnson
JNJ
$624B
$1.46M 1.46%
8,921
-353
-4% -$59.7K
UGI icon
45
UGI
UGI
$7.45B
$1.44M 1.45%
44,585
-1,596
-3% -$63K
TSN icon
46
Tyson Foods
TSN
$19.8B
$1.43M 1.44%
21,756
-778
-3% -$61.5K
VZ icon
47
Verizon
VZ
$196B
$1.37M 1.37%
36,010
-1,835
-5% -$81.7K
O icon
48
Realty Income
O
$58.7B
$1.35M 1.36%
23,216
-828
-3% -$57.1K
KEY icon
49
KeyCorp
KEY
$24.4B
$1.33M 1.34%
83,183
-2,976
-3% -$53.3K
CMCSA icon
50
Comcast
CMCSA
$90.5B
$1.29M 1.29%
43,873
-2,047
-4% -$76.5K
1
2
3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
SDP
Sentinel Dome Partners Burlingame, California $105M AUM
MAM
McLaughlin Asset Management Danville, Illinois $105M AUM
AF
Aldebaran Financial $105M AUM 19.84% 1-Year Est. Return
EEL
Expect Equity LLC Pikesville, Maryland $104M AUM 40.12% 1-Year Est. Return

Weaver C. Barksdale & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Weaver C. Barksdale & Associates held 65 positions worth $99.7M, down 7.2% from $107M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates's Q3 2022 filing shows 2 new, 1 increased, 60 reduced and 2 closed positions. Its largest new stake was Gilead Sciences: 29,289 shares worth $1.81M. The largest sale was 3M, an estimated $1.33M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q3 2022 buy was Gilead Sciences: 29,289 shares worth $1.81M.
  • Weaver C. Barksdale & Associates added most to Medtronic in Q3 2022, an estimated $31.9K increase.
  • Weaver C. Barksdale & Associates's biggest Q3 2022 reduction was Genuine Parts, cutting an estimated $288K.
  • Weaver C. Barksdale & Associates fully exited 3M in Q3 2022, selling an estimated $1.33M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $99.7M portfolio in Q3 2022.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q3 2022.
  • Weaver C. Barksdale & Associates's portfolio value fell 7.2% quarter-over-quarter to $99.7M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2022, filed 14 Nov 2022.